Biologic Treatments of Psoriasis: An Update for the Clinician
Nicholas D Brownstone, Julie Hong, Megan Mosca, Edward Hadeler, Wilson Liao, Tina Bhutani, John Koo University of California, San Francisco, Department of Dermatology, Psoriasis and Skin Treatment Center, San Francisco, CA, USACorrespondence: Nicholas D BrownstoneUniversity of California, San Franci...
Saved in:
Main Authors: | Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8d3701acd24e432b90c7f41db32b75cb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
by: el Hayderi L, et al.
Published: (2016) -
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
by: Beck KM, et al.
Published: (2018) -
Search for genetic markers of predisposition to psoriasis and psoriatic arthritis
by: M. V. Smolnikova, et al.
Published: (2020) -
Targeting IL-23 in psoriasis: current perspectives
by: Fotiadou C, et al.
Published: (2018) -
Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
by: Machado Á, et al.
Published: (2018)